Serum Institute of India

EU’s ‘Green Pass’ Plan Leaves Out Covishield, Serum Didn’t Apply for Approval

Appointed Experts Say They Didn’t Ask to Double Covishield Dose Gap, Govt Denies

New Covaxin Study Makes Absence of Phase 3 Data More Conspicuous

Study Finds Both Covaxin, Covishield Good – but Issues Mar Other Results

The Problems With One-Dose Covishield

Will Make, Supply 10 Cr Covishield Doses in June: Serum Institute to Centre

‘Four Months To Go From Manufacturing to Vaccination’: Bharat Biotech on Covaxin